Venom (VENOM) is currently trading at $0.161229, exhibiting a modest 24-hour price change of 0.52894%. The daily trading range has been tight, with a high of $0.162219 and a low of $0.16036, indicating relatively low volatility in the short term.

The trading volume stands at 224,030, which corresponds to a volume-to-market cap ratio of 0.07%, suggesting that trading activity is subdued relative to its market capitalization. An analysis of the hourly moving averages indicates a slight bearish trend, with the 8 SMA at $0.1614 down 0.13% and the 13 SMA at $0.1613 down 0.07%, while longer-term averages show some bullish momentum, notably the 55 SMA at $0.1608 up 0.29%.

The 1-hour RSI is currently at 60, indicating a potential overbought condition, while the 7-day RSI at 54 suggests that the asset is approaching neutral territory. However, the longer-term price changes reveal a concerning trend, with a 7-day decline of approximately 5.83%, a 14-day decline of about 12.79%, and a significant 30-day drop of 24.35%.

Given the current price action and technical indicators, the trend appears bearish in the medium to long term, despite some short-term recovery potential. The price is significantly below its all-time high of $0.782403, reached in March 2024, indicating a lack of upward momentum and investor confidence in the short term.

In conclusion, based on the technical indicators and recent price action, the recommendation for Venom (VENOM) is to Hold. The asset shows some potential for short-term recovery, but the longer-term declines and current resistance levels suggest caution for new positions.